Journal Information
Vol. 45. Issue S4.
HEMO 2023
Pages S332-S333 (October 2023)
Share
Share
Download PDF
More article options
Vol. 45. Issue S4.
HEMO 2023
Pages S332-S333 (October 2023)
Full text access
AN UPDATED OF PERIPHERAL T-CELL LYMPHOMA PATIENTS REGISTRY OF T-CELL BRAZIL PROJECT: A PROSPECTIVE COHORT ANALYSIS
Visits
262
CS Chiattonea,b, E Mirandac, SS Medinac, RLR Baptistad,e, J Pereiraf, SAB Brasilb, JV Tavaresg, KZ Cecyng, FL Nogueirah, M Bellossoi, DFC Fariasj, D Borducchik, NS Castrol, S Nabhanm, PPG Rakden, CCG Macedoo, CC Vilarimo, M Diasp, E Negreirosq, VLP Figueiredor..., DV Clés, R Schaffelt, RD Gaiollau, S Schusterschitzv, T Fischerw, GF Silvax, Y Gonzagay, N Zingz, AD Cunha-Jraa, JTD Souto-Filhoab, S Moa, EFO Ribeiroac, FB Duartead, RR Sousaad, MAL Matediae, MD Pontaf, N Hamerschlakag, G Periniah, YS Rabeloai, ND Buenoaj, P Curyak, A Hallack-Netoal, MT Delamainam, M Federicoan, CA SouzacVer más
a Hospital Samaritano, São Paulo, Brazil
b Faculdade de Ciências Médicas da Santa Casa São Paulo (FCMSCSP), São Paulo, Brazil
c Centro de Hematologia e Hemoterapia (Hemocentro), Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
d Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil
e Instituto D'Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Brazil
f Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil
g Hospital Ophir Loyola (HOL), Belém, Brazil
h Hospital Luxemburgo (HL), Instituto Mario Penna, Belo Horizonte, Brazil
i HemoMed, Instituto de Ensino e Pesquisa (IEP), São Paulo, Brazil
j A Beneficência Portuguesa de São Paulo (BP), São Paulo, Brazil
k Faculdade de Medicina do ABC (FMABC), Santo André, Brazil
l Hospital de Câncer de Barretos, Hospital de Amor de Barretos, Barretos, Brazil
m Universidade Federal do Paraná (UFPR), Curitiba, Brazil
n Casa de Saúde Santa Marcelina, São Paulo, Brazil
o Instituto de Ensino, Pesquisa e Inovação, Liga Contra o Câncer (CECAN), Natal, Brazil
p Universidade Federal da Bahia (UFBA), Salvador, Brazil
q Hospital de Amor Amazônia, Fundação Pio XII, Porto Velho, Brazil
r Hospital do Servidor Público do Estado de São Paulo (HSPE), Instituto de Assistência Médica ao Servidor Público Estadual (IAMSPE), São Paulo, Brazil
s Faculdade de Medicina de Ribeirão Preto (FMRP), Universidade de São Paulo (USP), Ribeirão Preto, Brazil
t Hospital Universitário Clementino Fraga Filho (HUCFF), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
u Faculdade de Medicina de Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, Brazil
v Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil
w AC Camargo Câncer Center, São Paulo, Brazil
x Hospital Aldenora Bello, São Luís, Brazil
y Instituto Nacional de Câncer (INCA), Brazil
z Prevent Senior, São Paulo, Brazil
aa Hematology and Oncology Clinics, Cancer Hospital of Cascavel, União Oeste Paranaense de Estudos e Combate ao Câncer (UOPECCAN), Cascavel, Brazil
ab Faculdade de Medicina de Campos (FMC), Campos dos Goytacazes, Brazil
ac Hospital Santa Lúcia, Brasília, Brazil
ad Hospital Universitário Walter Cantídio (HUWC), Universidade Federal do Ceará (UFC), Fortaleza, Brazil
ae Santa Casa de Belo Horizonte, Belo Horizonte, Brazil
af Centro de Pesquisas Oncológicas de Santa Catarina (CEPON), Florianópolis, Brazil
ag Hospital Israelita Albert Einstein (HIAE), São Paulo, Brazil
ah Hospital Paulistano, Oncologia Américas, São Paulo, Brazil
ai Universidade Federal de Goiás (UFG), Goiânia, Brazil
aj Frad Clínica Médica, Santo André, Brazil
ak Clínica São Germano, São Paulo, Brazil
al Universidade Federal de Juiz de Fora (UFJF), Juiz de Fora, MG, Brasil
am Faculdade Ciências Médicas de Minas Gerais (FCM-MG), Belo Horizonte, Brazil
an University of Modena and Reggio Emília, Italy
Ver más
This item has received
Article information
Special issue
This article is part of special issue:
Vol. 45. Issue S4

HEMO 2023

More info
Objectives

T-cell Brazil project started in April 2017 focusing to collecting epidemiological and clinical data from the most frequent subtypes of PTCL, as an ambispective study collected diagnosis data from January 2015 to December 2022. Our goals were to obtain the frequency of subtypes and the clinical and biology characteristic from five Brazilian regions; besides to have a routine pathological revision and to evaluate the Overall Survival (OS), Progression-Free Survival (PFS) in 5 years of follow-up.

Method

After 39 centers were approved by their Ethical Committee, they registered their cases using the REDcap Platform by Vanderbilt, being 63% public centers. Here, It was just analyzed a Prospective Cohort (PC), with diagnosis date from April 2017 to December 2022, a total of 461 cases. Descriptive analyses, Kaplan-Meier method, Log-Rank test to compare groups and Cox Regression to identify risk factor for OS using IBM-SPSS software v.24.

Results

The median age was 52 years (18-92); 58% male; Almost 72% had advanced stages, 25% ECOG ≥ 2; the distribution of main subtypes was: 30% PTCL-NOS; 18% ALCL, ALK-; 14% ATL; 13% ENKTL-NT; 10.5% AITL; 5% ALCL, ALK+; 9.5% others. A median of follow up of 22 months (0-73), 55% pts were alive and 24-month PFS and OS were 36% and 49%, respectively. OS by main subtypes was 69% ALCL, ALK+; 61% ALCL, ALK; 50% PTCL-NOS; 44% ENKTL-NT; 41% AITL; 27% ATL. Cox regression showed ATL (HR 1.6, p = 0.008), ECOG ≥ 2 (HR 1.86, p < 0.0001) and Ann Arbor Stage III-IV (HR 2.06, p < 0.0001) as bad prognosis for OS; whereas for PFS were ATL (HR 1.9, p < 0.0001); ECOG≥ 2 (HR 1.53, p = 0.002); Ann Arbor Stage III-IV (HR 1.75, p = 0.001) and B symptoms (HR 1.36, p = 0.02). Discussion: PTCL make up approximately 10-15% of lymphoid malignancies and its frequency varies geographically. In Brazil, mainly due to its vast dimension, data collection has limitations and is subject to bias. This is the first experience cover all over the country, focusing also an educational and of interchanging experience network among the multidisciplinary health team in Brazil.

Conclusions

Our initial target of 500 pts exceeded, hence the number of prospective cohort is getting close, because we are in a consistency data phase and probably more cases will be available after that. So, it is possible to make analyzes with PC. ATL and ENKTL-NT subtype presented more frequent of all, different of the Occidental countries, but similar with recent data from American Latin.

Full text is only aviable in PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools